MURKY
发表于 2025-3-25 03:50:03
http://reply.papertrans.cn/29/2831/283096/283096_21.png
MAIZE
发表于 2025-3-25 07:37:40
http://reply.papertrans.cn/29/2831/283096/283096_22.png
Oafishness
发表于 2025-3-25 12:27:39
ntimalarial and antiprotozoal drug classes.New chapters dedi.The 4.th. edition of .Drug Interactions in Infectious Diseases .is being split into two separate volumes – “Mechanisms and Models of Drug Interactions” and “Antimicrobial Drug Interactions”. ..This volume, “Antimicrobial Drug Interactions,
Coma704
发表于 2025-3-25 17:06:01
Anshuman Behera,Areeba Ahsanat Moazzam the treatment of tuberculosis and human immunodeficiency virus is discussed. Most drug interactions with antituberculosis drugs are a result of effects on hepatic enzyme metabolism. Interactions with drugs affecting absorption also are reviewed.
上下倒置
发表于 2025-3-25 21:14:20
Anshuman Behera,Areeba Ahsanat Moazzamass is also being investigated as part of nucleos(t)ide analog-sparing regimens and as long-acting injectables for HIV treatment and prevention. This chapter reviews the pharmacology and drug interaction potential of PIs and INIs used in the treatment of HIV with summary tables to guide patient management.
Chronic
发表于 2025-3-26 03:18:33
http://reply.papertrans.cn/29/2831/283096/283096_26.png
deficiency
发表于 2025-3-26 08:10:42
Vision-and-Language Pretraining for VQArmacokinetic properties and drug interaction potential of agents used in the treatment of hepatitis B and C viruses, as well as pharmacologic considerations on the use of these therapies in patients with renal or hepatic impairment.
母猪
发表于 2025-3-26 10:42:12
http://reply.papertrans.cn/29/2831/283096/283096_28.png
鸽子
发表于 2025-3-26 14:08:14
Drug Interactions in HIV: Nucleoside, Nucleotide, and Nonnucleoside Reverse Transcriptase Inhibitor CCR5 antagonist, maraviroc, may also be victims of drug-drug interactions related to cytochrome P450 metabolism. This chapter emphasizes the clinical significance and management of common drug interactions associated with these antiretroviral drug classes.
一起
发表于 2025-3-26 17:33:37
Hepatitis B and Hepatitis C Antiviral Agents,rmacokinetic properties and drug interaction potential of agents used in the treatment of hepatitis B and C viruses, as well as pharmacologic considerations on the use of these therapies in patients with renal or hepatic impairment.